Netherlands: Sexual dysfunction is a significant yet often overlooked issue in patients with chronic inflammatory diseases, ...

RAMAT GAN, Israel, Oct. 09, 2024 (GLOBE NEWSWIRE) -- (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a ...

The trial will compare the therapy to radical prostatectomy and could unlock a market that analysts value at $500 million.

Researchers have found more promising ways the infant food can benefit health – aside from being a nutritional supplement and ...